Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 β-form in human gliomas

Genes and Genetic Systems

Volumn 83, Issue 4, 2008, Pages 347-352

  Gu, Zhaodi ^a   Inomata, Kenichi ^a   Mitsui, Hidetoshi ^a   Horii, Akira ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FBXW7; Human glioma; Methylation; Peripheral blood cells

Indexed keywords

AZACITIDINE; BISULFITE; MESSENGER RNA; TRICHOSTATIN A;

ARTICLE; CHROMOSOME 4Q; CONTROLLED STUDY; CPG ISLAND; EXON; FBXW7 GENE; GENE INACTIVATION; GENE REPRESSION; GENE SILENCING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; NEUROPATHOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN VARIANT; TUMOR SUPPRESSOR GENE;

AZACITIDINE; BASE SEQUENCE; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; ENZYME INHIBITORS; F-BOX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOMA; HUMANS; HYDROXAMIC ACIDS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); UBIQUITIN-PROTEIN LIGASES;

EID: 54249138586     PISSN: 13417568     EISSN: None     Source Type: Journal    
DOI: 10.1266/ggs.83.347     Document Type: Article

References (29)

1. Aifantis, I., Raetz, E., and Buonamici, S. (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat. Rev. Immunol. 8, 380-390.
2. Akhoondi, S., Sun, D., von der Lehr, N., Apostolidou, S., Klotz, K., Maljukova, A., Cepeda, D., Fiegl, H., Dofou, D., Marth, C., et al. (2007) FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 67, 9006-9012.
3. Balakrishnan, A., Bleeker, F. E., Lamba, S., Rodolfo, M., Daniotti, M., Scarpa, A., van Tilborg, A. A., Leenstra, S., Zanon, C., and Bardelli, A. (2007) Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res. 67, 3545-3550.
4. Barlow, D. P. (1995) Gametic imprinting in mammals. Science 270, 1610-1613.
5. Baylin, S. B. (2005) DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2 Suppl 1, S4-S11.
6. Calhoun, E. S., Jones, J. B., Ashfaq, R., Adsay, V., Baker, S. J., Valentine, V., Hempen, P. M., Hilgers, W., Yeo, C. J., Hruban, R. H., et al. (2003) BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: Potential therapeutic targets. Am. J. Pathol. 163, 1255-1260.
7. Fukami, T., Nakasu, S., Baba, K., Nakajima, M., and Matsuda, M. (2004) Hyperthermia induces translocation of apoptosis-inducing factor (AIF) and apoptosis in human glioma cell lines. J. Neuro-Oncol. 70, 319-331.
8. Gomez-Manzano, C., Fueyo, J., Kyritsis, A. P., Steck, P. A., Roth, J. A., McDonnell, T. J., Steck, K. D., Levin, V. A., and Yung, W. K. (1996) Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 56, 694-699.
9. Goto, T., and Monk, M. (1998) Regulation of X-chromosome inactivation in development in mice and humans. Microbiol. Mol. Biol. Rev. 62, 362-378.
10. Gu, Z., Inomata, K., Ishizawa, K., and Horii, A. (2007) The FBXW7 β-form is suppressed in human glioma cells. Biochem. Biophys. Res. Commun. 354, 992-998.
11. Hagedorn, M., Delugin, M., Abraldes, I., Allain, N., Belaud-Rotureau, M. A., Turmo, M., Prigent, C., Loiseau, H., Bikfalvi, A., and Javerzat, S. (2007) FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients. Cell Div. 2, 9.
12. Hu, J., Jiang, C., Ng, H. K., Pang, J. C., Tong, C. Y., and Chen, S. (2003) Genome-wide allelotype study of primary glioblastoma multiforme. Chin. Med. J. 116, 577-583.
13. Jia, L. Q., Osada, M., Ishioka, C., Gamo, M., Ikawa, S., Suzuki, T., Shimodaira, H., Niitani, T., Kudo, T., Akiyama, M., et al. (1997) Screening the p53 status of human cell lines using a yeast functional assay. Mol. Carcinog. 19, 243-253.
14. Kemp, Z., Rowan, A., Chambers, W., Wortham, N., Halford, S., Sieber, O., Mortensen, N., von Herbay, A., Gunther, T., Ilyas, M., and Tomlinson, I. (2005) CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. Cancer Res. 65, 11361-11366.
15. Kimura, T., Gotoh, M., Nakamura, Y., and Arakawa, H. (2003) hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53. Cancer Sci. 94, 431-436.
16. Malyukova, A., Dohda, T., von der Lehr, N., Akhondi, S., Corcoran, M., Heyman, M., Spruck, C., Grander, D., Lendahl, U., and Sangfelt, O. (2007) The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res. 67, 5611-5616.
17. Mori, Y., Shiwaku, H., Fukushige, S., Wakatsuki, S., Sato, M., Nukiwa, T., and Horii, A. (1997) Alternative splicing of hMSH2 in normal human tissues. Hum. Genet. 99, 590-595.
18. Nakayama, K. I., and Nakayama, K. (2005) Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 16, 323-333.
19. Ogawa, K., Shiga, K., Saijo, S., Ogawa, T., Kimura, N., and Horii, A. (2006) A novel G106D alteration of the SDHD gene in a pedigree with familial paraganglioma. Am. J. Med. Genet. A 140, 2441-2446.
20. Onoyama, I., Tsunematsu, R., Matsumoto, A., Kimura, T., de Alborán, I. M., Nakayama, K., and Nakayama, K. I. (2007) Conditional inactivation of Fbxw7 impairs cell-cycle exit during T-cell differentiation and results in lymphomatogenesis. J. Exp. Med. 204, 2875-2888.
21. Cdc4 ubiquitin ligase. Cell 112, 243-256.
22. Rajagopalan, H., Jallepalli, P. V., Rago, C., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., and Lengauer, C. (2004) Inactivation of hCDC4 can cause chromosomal instability. Nature 428, 77-81.
23. Sakurada, A., Suzuki, A., Sato, M., Yamakawa, H., Orikasa, K., Uyeno, S., Ono, T., Ohuchi, N., Fujimura, S., and Horii, A. (1997) Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary. Jpn. J. Cancer Res. 88, 1025-1028.
24. Spruck, C. H., Strohmaier, H., Sangfelt, O., Muller, H. M., Hubalek, M., Muller-Holzner, E., Marth, C., Widschwendter, M., and Reed, S. I. (2002) hCDC4 gene mutations in endometrial cancer. Cancer Res. 62, 4535-4539.
25. Strohmaier, H., Spruck, C. H., Kaiser, P., Won, K. A., Sangfelt, O., and Reed, S. I. (2001) Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413, 316-322.
26. FBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med. 207, 1825-1835.
27. Van Meir, E. G., Kikuchi, T., Tada, M., Li, H., Diserens, A. C., Wojcik, B. E., Huang, H. J., Friedmann, T., de Tribolet, N., and Cavenee, W. K. (1994) Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 54, 649-652.
28. Welcker, M., and Clurman, B. E. (2008) FBW7 ubiquitin ligase: A tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 8, 83-93.
29. Xu, S., Furukawa, T., Kanai, N., Sunamura, M., and Horii, A. (2005) Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. J. Hum. Genet. 50, 159-167.